BRCA1 and neoplasm: Other recommendations from phase 1 participants included adding information on the most common types of hereditary CRC syndromes (eg, Lynch syndrome, familial adenomatous polyposis), clarifying which patients are most at risk or in need of testing, distinguishing between GT and somatic/tumor testing, addressing incidental findings from GT (eg, beyond CRC, such as BRCA1), defining specific gene associations, discussing treatment options based on variants, reducing redundancies in “informed consent,” and communicating clearly to lay audiences (eg, clarifying language and providing examples).